GlaxoSmithKline Loses Bid to End Zofran Lawsuits By Sam | October 25, 2019 GlaxoSmithKline lost its bid to end multiple lawsuits against the company alleging that its anti-nausea drug Zofran (ondansetron) caused birth defects. Source: Drug Industry Daily Posted in Drug Industry Daily